Exclusive

Exclusive Bob Herman

STAT Plus: As Humira biosimilars take over the market, CVS has created a new ploy: the drug ‘rebate credit’

Exclusive Bob Herman

STAT Plus: UnitedHealth is on a buying spree of outpatient surgery centers

Exclusive Allison DeAngelis

STAT Plus: Biotech FogPharma raises $145 million in anticipation of more clinical trials, pharma partnerships

Exclusive Lizzy Lawrence

STAT Plus: Medical device lobby says it’s tired of waiting on Medicare to cover breakthrough devices

Exclusive Brittany Trang

STAT Plus: Change Healthcare cyberattack outage could persist for weeks, UnitedHealth Group executive suggests

Exclusive Allison DeAngelis

STAT Plus: Biotech launches with $82 million for Parkinson’s cell therapy

Exclusive Ed Silverman

STAT Plus: White House to hold a listening session on reforming pharmacy benefit managers

Exclusive Angus Chen

MD Anderson tried — and failed — to resolve research credit dispute between two scientists, new documents show

Exclusive Sarah Owermohle

Key congressman blasts HHS for lack of cooperation on Covid-19

Exclusive Rachel Cohrs Zhang

STAT Plus: Senators start work on Medicare physician payment reform

Exclusive Angus Chen and Jonathan Wosen

STAT Plus: A junior scientist. A prominent oncologist. Now, a clash at MD Anderson over who gets research credit

Exclusive Helen Branswell

STAT Plus: HHS leaves vacant more than half the slots on a key vaccine advisory panel

Exclusive Megan Molteni

Texas Medicaid agrees to fully cover gene therapy for Afghan refugees’ infant

Exclusive Mario Aguilar

STAT Plus: AI therapy and ICU training: A first look at health apps for Apple Vision Pro

Exclusive Jonathan Wosen

STAT Plus: Ultima Genomics launching high-end DNA sequencers that can read genome for $100

Exclusive Rachel Cohrs Zhang

STAT Plus: Congress’ negotiations over doc pay, health centers fell apart ahead of spending extension

Exclusive Jason Mast

STAT Plus: Dewpoint Therapeutics cuts 15% of staff, acknowledges Merck, Pfizer broke off partnerships over buzzy science

Exclusive Megan Molteni

STAT Plus: The Afghan father aided U.S. soldiers. Now Texas Medicaid won’t pay for his son’s gene therapy

Exclusive Allison DeAngelis

STAT Plus: Former Sage executives join biotech VC Cure Ventures

Exclusive Casey Ross

STAT Plus: Backed by Mayo Clinic and Microsoft, a nonprofit forms to test AI tools used in health care

Exclusive Matthew Herper

STAT Plus: Insitro, biotech AI��s quiet unicorn, unveils efforts in ALS, liver disease, and cancer at JPM

Exclusive Jason Mast

STAT Plus: Feng Zhang’s year-old CRISPR delivery startup Aera lays off quarter of staff

Exclusive Matthew Herper

STAT Plus: Amy Abernethy to step down as Verily’s chief medical officer in latest departure from company

Exclusive Annalisa Merelli

STAT Plus: Male birth control gets another shot with small new trial of non-hormonal pill

Exclusive Matthew Herper

STAT Plus: Sanofi says it has 12 blockbusters in its back pocket. Will investors believe it?

Exclusive Lev Facher and Rachel Cohrs Zhang

STAT Plus: Sweeping bill to fight opioid addiction will be considered by Senate health committee

Exclusive Theresa Gaffney

The push to get estrogen FDA-approved for gender-affirming care

Exclusive Matthew Herper

STAT Plus: CRISPR’s pioneers reflect on the first gene-editing treatment

Exclusive Sarah Owermohle

STAT Plus: FDA’s latest reorganization puts a new emphasis on its investigations